Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review

Joseph D Tobias1,2,3

  • 1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.

PubMed

Insights

Remimazolam, an ultrashort-acting benzodiazepine, offers rapid sedation and recovery via tissue esterase metabolism. Its use in pediatric patients is under investigation, with limited data currently available for this off-label application.

Area of Science:

  • Pharmacology
  • Anesthesiology

Background:

  • Remimazolam is a novel, ultrashort-acting benzodiazepine approved for adult procedural sedation and anesthesia.
  • Unlike midazolam, remimazolam is metabolized by tissue esterases, leading to rapid elimination and quick recovery.
  • Limited data exists on remimazolam's efficacy and safety in pediatric populations.

Purpose of the Study:

  • To outline the pharmacologic properties of remimazolam.
  • To review existing literature on remimazolam use in pediatric patients.
  • To discuss dosing and clinical application of remimazolam in children.

Main Methods:

  • Pharmacological profile review.
  • Literature search for pediatric case reports and clinical trials.
  • Analysis of published dosing parameters and clinical outcomes.

Main Results:

  • Remimazolam exhibits rapid onset and offset of action due to esterase metabolism.
  • Preliminary adult data suggest efficacy and safety for procedural sedation and anesthesia.
  • Published pediatric data are scarce, highlighting a gap in knowledge.

Conclusions:

  • Remimazolam's unique pharmacokinetic profile is advantageous for procedural sedation.
  • Further research is warranted to establish safety and efficacy in pediatric patients.
  • Off-label use in children requires careful consideration and monitoring.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
114
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
250
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
326
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
230
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
175